Emerging research suggest this peptide, a dual stimulator targeting both the gut-brain axis and GIP , appears to provide a notable development for obesity loss . Initial human investigations have demonstrated substantial losses in abdominal tissue, conceivably exceeding existing obesity therapies . Nevertheless , further evaluation is needed to ful